FDA Inspection 1012798 — Bracco Diagnostics, Inc.

Bracco Diagnostics, Inc. — FEI 1000307800

The FDA completed an inspection of Bracco Diagnostics, Inc. on Jun 5, 2017 in Princeton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 5, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.